Schedule 13G ownership disclosure
Millendo Therapeutics, Inc.
Security class unavailable · CUSIP: 60040X103
Event date: 2020-04-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-101340
- Form type
- SC 13G
- Filer
- Frazier Healthcare VI, L.P.
- CIK
- CIK 1456656
- Filed
- Apr 08, 2020
- Reporting period
- Apr 06, 2020
- Description
- Schedule 13G beneficial ownership